As of now, studies have revealed that targeting PKM2 can, not only, mediate the biological activity of cancer cells, but also affect the effectiveness of therapies towards cancer, such as, in pancreatic cancer cells. The gene discussed is PKM; the disease is familial pancreatic carcinoma.